Business Description
Bionet Therapeutics Corp
ISIN : TW0007808008
Total Employee Number:
97Description
Bionet Therapeutics Corp is a patient-focused on regenerative medicinal products, R&D, exosomes, and gene/cell therapy biopharmaceutical company. The group develops, manufactures, and provides regenerative medicine preparations and cellular therapies to meet the evolving health needs of people at different stages of life. It focused on treatments that improve patient outcomes. It provides Cell Therapy Products and CRDMO Services.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 94.75 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 19.35 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 43.2 | |||||
3-Year EPS without NRI Growth Rate | 40.7 | |||||
3-Year FCF Growth Rate | -2.8 | |||||
3-Year Book Growth Rate | 192.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.06 | |||||
9-Day RSI | 35.01 | |||||
14-Day RSI | 33.47 | |||||
3-1 Month Momentum % | -15.68 | |||||
6-1 Month Momentum % | -32.38 | |||||
12-1 Month Momentum % | -32.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 19.7 | |||||
Quick Ratio | 19.18 | |||||
Cash Ratio | 18.35 | |||||
Days Inventory | 120.36 | |||||
Days Sales Outstanding | 39.04 | |||||
Days Payable | 43.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.91 | |||||
Operating Margin % | -75.37 | |||||
Net Margin % | -63.07 | |||||
EBITDA Margin % | -55.4 | |||||
FCF Margin % | -91.06 | |||||
OCF Margin % | -37.21 | |||||
ROE % | -7.76 | |||||
ROA % | -7.43 | |||||
ROIC % | -87.94 | |||||
ROC (Joel Greenblatt) % | -93.57 | |||||
ROCE % | -7.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 13.16 | |||||
PB Ratio | 1.68 | |||||
Price-to-Tangible-Book | 1.68 | |||||
EV-to-EBIT | -10.13 | |||||
EV-to-EBITDA | -11.51 | |||||
EV-to-Revenue | 6.37 | |||||
EV-to-FCF | -7.55 | |||||
| Price-to-Net-Current-Asset-Value | 1.9 | |||||
| Price-to-Net-Cash | 2.05 | |||||
Earnings Yield (Greenblatt) % | -9.89 | |||||
FCF Yield % | -6.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionet Therapeutics Corp Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 154.478 | ||
| EPS (TTM) (NT$) | -1.395 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 35.59 | ||
| 14-Day RSI | 33.47 | ||
| 14-Day ATR (NT$) | 1.074599 | ||
| 20-Day SMA (NT$) | 30.3075 | ||
| 12-1 Month Momentum % | -32.12 | ||
| 52-Week Range (NT$) | 28.55 - 66.3 | ||
| Shares Outstanding (Mil) | 70 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionet Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionet Therapeutics Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bionet Therapeutics Corp Frequently Asked Questions
What is Bionet Therapeutics Corp(ROCO:7808)'s stock price today?
The current price of ROCO:7808 is NT$29.05. The 52 week high of ROCO:7808 is NT$66.30 and 52 week low is NT$28.55.
When is next earnings date of Bionet Therapeutics Corp(ROCO:7808)?
The next earnings date of Bionet Therapeutics Corp(ROCO:7808) is .
Does Bionet Therapeutics Corp(ROCO:7808) pay dividends? If so, how much?
Bionet Therapeutics Corp(ROCO:7808) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bionet Therapeutics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers